Expression of PPARγ and β/δ in human primary osteoblastic cells: Influence of polyunsaturated fatty acids

Calcified Tissue International

Volumn 76, Issue 5, 2005, Pages 385-392

  Maurin, A C ^a   Chavassieux, P M ^a   Meunier, P J ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Fatty acid; Osteoblast; PPARs

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; TRANSCRIPTION FACTOR; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; ARACHIDONIC ACID; BIOLOGICAL RESPONSE MODIFIER; CARBACYCLIN; DOCOSAHEXAENOIC ACID; DRUG DERIVATIVE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN D2;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL STRAIN 3T3; CELL SURVIVAL; GENETICS; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; ANIMALS; ARACHIDONIC ACID; BIOLOGICAL RESPONSE MODIFIERS; CELL PROLIFERATION; CELL SURVIVAL; DOCOSAHEXAENOIC ACIDS; EPOPROSTENOL; HUMANS; MICE; OSTEOBLASTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 23944469952     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0108-y     Document Type: Article

References (53)

1. Meunier P, Aaron J, Edouard C, Vignon G (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop 80:147-154
2. Maurin AC, Chavassieux PM, Frappart L, Delmas PD, Serre CM, Meunier PJ (2000) Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone 26:485-489
3. Maurin AC, Chavassieux PM, Vericel E, Meunier PJ (2002) Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 31:260-266
4. Stillwell W, Ehringer W, Jenski LJ (1993) Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells. Lipids 28:103-108
5. Jump DB (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13:155-164
6. Corey EJ, Shih C, Cashman JR (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 80:3581-3584
7. Lesage F, Maingret F, Lazdunski M (2000) Cloning and expression of human TRAAK, a polyunsaturated fatty acids-activated and mechano-sensitive K(+) channel. FEBS Lett 471:137-140
8. Wilding TJ, Chai YH, Huettner JE (1998) Inhibition of rat neuronal kainate receptors by cis-unsaturated fatty acids. J Physiol 513:331-339
9. Nabekura J, Noguchi K, Witt MR, Nielsen M, Akaike N (1998) Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosa-hexaenoic acid. J Biol Chem 273:11056-11061
10. Graber R, Sumida C, Nunez EA (1994) Fatty acids and cell signal transduction. J Lipid Mediat Cell Signal 9:91-116
11. Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD, Weeber EJ (2001) Protein kinase inhibition by omega-3 fatty acids. J Biol Chem 276:10888-10896
12. Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani MU, Barrera G (2003) Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther 305:932-942
13. Sellmayer A, Danesch U, Weber PC (1996) Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. Lipids 31(Suppl): S37-S40
14. Duplus E, Glorian M, Forest C (2000) Fatty acid regulation of gene transcription. J Biol Chem 275:30749-30752
15. Pegorier JP, Le May C, Girard J (2004) Control of gene expression by fatty acids. J Nutr 134:24448-24498
16. Hihi AK, Michalik L, Wahli W (2002) PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol Life Sci 59:790-798
17. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270:23975-23983
18. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819
19. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812
20. Hertz R, Berman I, Keppler D, Bar-Tana J (1996) Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome- proliferators-activated receptor (PPAR). Eur J Biochem 235:242-247
21. Diascro DD, Vogel RL Jr, Johnson TE, Witherup KM, Pitzenberger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A (1998) High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106
22. Cecchini MG, Portenier J, Wetterwald A, Braissant O, Wahli W (1997) Expression of peroxisome proliferator activated receptors in rat bone. J Bone Miner Res 12(suppl 1):S458
23. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13:371-382
24. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC (1996) Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50:1087-1094
25. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR gamma 2. J Cell Biochem 74:357-371
26. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376-2384
27. Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, Park SW, Kim SY, Shin CS (2003) Activation of peroxisome proliferator-activated receptor-γ inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278:23270-23277
28. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H (2004) PPAR gamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855
29. hyp/hyp mice relocates hematopoiesis to the spleen. EMBO J 10:1007-1012
30. Sorocéanu MA, Maio D, Bai XY, Su H, Goltzman D, Karaplis AC (2004) Rosiglitazone impacts negatively on bone promoting osteoblast/osteocyte apoptosis. J Endocrinol 183:203-216
31. Rzonca SO, Silva LJ, Gaddy D, Montague DC, Lecka-Czernik B (2004) Bone is a target for the antidiabetic compound rosiglitazone. Endocrinol 145:401-406
32. Kelly IE, Man TS, Walsh K, Lean MEJ (1999) Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22:288-293
33. Grimaldi PA (2001) The roles of PPARs in adipocyte differentiation. Prog Lipid Res 40:269-281
34. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293-1307
35. Mandrup S, Lane MD (1997) Regulating adipogenesis. J Biol Chem 272:5367-5370
36. Bastie C, Holst D, Gaillard D, Jehl-Pietri C, Grimaldi PA (1999) Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts. J Biol Chem 274:21920-21925
37. Altiok S, Xu M, Spiegelman BM (1997) PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11:1987-1998
38. Shao D, Lazar MA (1997) Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem 272:21473-21478
39. Chavassieux PM, Chenu C, Valentin-Opran A, Merle B, Delmas PD, Hartmann DJ, Saez S, Meunier PJ (1990) Influence of experimental conditions on osteoblast activity in human primary bone cell cultures. J Bone Miner Res 5:337-343
40. Richieri GV, Anel A, Kleinfeld AM (1993) Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 32:7574-7580
41. Lanotte M, Scott D, Dexter TM, Allen TD (1982) Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro. J Cell Physiol 111:177-186
42. Rosen ED, Spiegelman BM (2001) PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734
43. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641
44. Wang C, Fu M, D'Amico M, Albanese C, Zhou JN, Brownlee M, Lisanti MP, Chatterjee VK, Lazar MA, Pestell RG (2001) Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol Cell Biol 21:3057-3010
45. Miwa Y, Sasaguri T, Inoue H, Taba Y, Ishida A, Abumiya T (2000) 15-Deoxy-delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells. Mol Pharmacol 58:837-844
46. Wakino S, Kintscher U, Kim S, Yin F, Hsueh WA, Law RE (2000) Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells. J Biol Chem 275:22435-22441
47. Glantschnig H, Varga F, Klaushofer K (1996) The cellular protooncogenes c-fos and egr-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts. Endocrinology 137:4536-4541
48. Zhang J, Fu M, Zhu X, Xiao Y, Mou Y, Zheng H, Akinbami MA, Wang Q, Chen YE (2002) zPeroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J Biol Chem 277:11505-11512
49. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
50. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270:28183-28187
51. Khan E, Abu-Amer Y (2003) Activation of peroxisome proliferator-activated receptor-γ inhibits differentiation of preosteoblasts. J Lab Clin Med 142:29-34
52. Pei L, Tontonoz P (2004) Fat's loss is bone's gain. J Clin Invest 113:805-806
53. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I (2002) Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol 37:757-767